Can SMR Stock Beat the Market?
NuScale has gone from market outperformer to underperformer, but don’t rule out this nuclear technology company’s chances of returning to outsized price performance.
A month ago, if you asked whether NuScale Power (SMR 6.29%) was beating the market, you could answer, “yes.”
» Read more about: Can SMR Stock Beat the Market? »
Read MoreCLSA expects Macau GGR to grow 5pct in 2026, operators dividends to increase
A “stronger renminbi versus the [U.S.] dollar and a currently positive industrial profit indicator in China should drive” Macau casino gross gaming revenue (GGR) growth in 2026, suggested CLSA in a Wednesday memo.
“We project Macau’s GGR to grow 5 percent year-on-year to US$32.3 billion, implying a daily GGR of MOP709 million [US$88.5 million] per day,” wrote analysts Jeffrey Kiang and Leo Pan.
» Read more about: CLSA expects Macau GGR to grow 5pct in 2026, operators dividends to increase »
Read MoreAs Tesla Falters In China, This Local Rival Is Roaring Ahead: Big Spike In Growth Scores
Automaker Tesla Inc.’s (NASDAQ:TSLA) momentum in China has stalled in recent weeks, with the company seeing a 9.9% year-over-year decline in the world’s second-largest economy in October.
At the same time,
Why New Fortress Energy Stock Plummeted 7.4% Today
Key Points
Shares of New Fortress Energy (NASDAQ: NFE) fell on Tuesday, finishing down 7.4%. The drop came as the S&P 500 and Nasdaq Composite gained 0.9% and 0.6%,
» Read more about: Why New Fortress Energy Stock Plummeted 7.4% Today »
Read MoreHere Are Billionaire Warren Buffett's 5 Biggest Stock Holdings
Key Points
Billionaire Warren Buffett and his company, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B),
» Read more about: Here Are Billionaire Warren Buffett's 5 Biggest Stock Holdings »
Read MoreThe Burst
Market Commentary: The Meteoric Rise of Eli Lilly
Did you know that Eli Lilly and other pharmaceutical companies have sold approximately 10.6 million shots of obesity drug doses in the U.S. in a single month? The rise of these injectable weight loss medications is so powerful that it’s causing investors to question the future of even staple food and beverage stocks.
While this aspect alone could secure Eli Lilly as the pharmaceutical golden goose you’ve been looking for there is much more than meets the eye.
» Read more about: Market Commentary: The Meteoric Rise of Eli Lilly »
Read MoreThe Ivy
36 Stocks Up 30% Year-to-Date
Famously, a common pitfall of ordinary traders is to buy the dip and ignore the stocks going from strength to strength. It’s just so tempting to buy stocks that have sold off in the hopes of making the big returns while ignoring those powering higher from one day to the next.
If we turn our attention to those stocks that have been going higher this year,
» Read more about: 36 Stocks Up 30% Year-to-Date »
Read More